<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04072250</url>
  </required_header>
  <id_info>
    <org_study_id>201701127B0</org_study_id>
    <nct_id>NCT04072250</nct_id>
  </id_info>
  <brief_title>Surgery for Recurrent Intrahepatic Cholangiocarcinoma</brief_title>
  <official_title>Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators retrospectively reviewed the participants suffering from recurrent
      intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive
      factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with
      metastasectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Actual">October 30, 2018</completion_date>
  <primary_completion_date type="Actual">October 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>1977~2014</time_frame>
    <description>Including overall survival and disease free survival</description>
  </primary_outcome>
  <enrollment type="Actual">216</enrollment>
  <condition>Cholangiocarcinoma, Intrahepatic</condition>
  <condition>Recurrence Cholangiocarcinoma</condition>
  <condition>Re-hepatectomy</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hepatectomy</intervention_name>
    <description>Hepatectomy for patients with recurrent intrahepatic cholanigocarcinoma</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Between January 1977 and December 2014, 452 patients underwent curative-intent, different
        extent of hepatectomy for ICC in the Department of General Surgery, Chang Gung Memorial
        Hospital, Linkou branch, Taiwan. Only 216 patients fulfilled selection criteria
        aforementioned.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis.

        Exclusion Criteria:

          -  (1)Patient with R1 or R2 resection

          -  (2)Distant metastasis noted when laparotomy

          -  (3)Surgical mortality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital Linkou Branch</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>August 26, 2019</study_first_submitted>
  <study_first_submitted_qc>August 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>September 11, 2019</last_update_submitted>
  <last_update_submitted_qc>September 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Recurrent intrahepatic cholangiocarcinoma</keyword>
  <keyword>Intrahepatic cholangiocarcinoma</keyword>
  <keyword>Repeat hepatectomy</keyword>
  <keyword>Metastasectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

